| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3263684
Max Phase: Preclinical
Molecular Formula: C25H29N5O3
Molecular Weight: 447.54
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1ccccc1N1CCN(c2ccc(C(=O)NCCN)cc2NC(=O)c2ccco2)CC1
Standard InChI: InChI=1S/C25H29N5O3/c1-18-5-2-3-6-21(18)29-12-14-30(15-13-29)22-9-8-19(24(31)27-11-10-26)17-20(22)28-25(32)23-7-4-16-33-23/h2-9,16-17H,10-15,26H2,1H3,(H,27,31)(H,28,32)
Standard InChI Key: GBKGEVJVIPUJIV-UHFFFAOYSA-N
Associated Targets(Human)
Follicle stimulating hormone receptor 234 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 447.54 | Molecular Weight (Monoisotopic): 447.2270 | AlogP: 2.86 | #Rotatable Bonds: 7 |
| Polar Surface Area: 103.84 | Molecular Species: BASE | HBA: 6 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.52 | CX Basic pKa: 9.16 | CX LogP: 2.76 | CX LogD: 1.01 |
| Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.51 | Np Likeness Score: -1.61 |
References
| 1. Yu HN, Richardson TE, Nataraja S, Fischer DJ, Sriraman V, Jiang X, Bharathi P, Foglesong RJ, Haxell TF, Heasley BH, Jenks M, Li J, Dugas MS, Collis R, Tian H, Palmer S, Goutopoulos A.. (2014) Discovery of substituted benzamides as follicle stimulating hormone receptor allosteric modulators., 24 (9): [PMID:24685543] [10.1016/j.bmcl.2014.03.018] |
Source
Source(1):